Method of inhibiting leukemias and sarcomas in a mammalian host

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514256, 546 65, A61K 3147

Patent

active

048660710

ABSTRACT:
A new antineoplastic substance denominated "pancratistatin". Methods of isolating natural and synthetic pancratistatin and 7-deoxynarciclasine and the pharmaceutically acceptable derivatives thereof to make a pharmaceutical preparation therefrom and methods for treating a host afflicted with a neoplasm with said preparations.

REFERENCES:
patent: 3588993 (1971-06-01), Okamoto et al.
Keck et al., "Synthetic Studies on Lycoricidine", Tetra. Let., vol. 22, No. 28, pp. 2615-2618 (1981).
Mondon et al., "Zur Kenntnis des Narciclasins", Chem. Ber., 108, pp. 445-463 (1975).
Pettit et al., "Isolation and Structure of Pancratistan", Journ. Chem. Soc. Chem. Comm., pp. 1693-1694 (1984).
Piozzi, "Narciclasine and Narciprimine", Tetra., vol. 24, pp. 1119-1131 (1968).
Keek et al., Tetrahedron Letters, vol. (22), No. 28, pp. 2615-2618 (1981).
Piozzi et al., Tetrahedron, vol. 24, pp. 1119-1131 (1968).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of inhibiting leukemias and sarcomas in a mammalian host does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting leukemias and sarcomas in a mammalian host, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting leukemias and sarcomas in a mammalian host will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-916498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.